123 related articles for article (PubMed ID: 11489908)
1. Interaction of Met297 in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A.
Labrou NE; Bhogal N; Hurrell CR; Findlay JB
J Biol Chem; 2001 Oct; 276(41):37944-9. PubMed ID: 11489908
[TBL] [Abstract][Full Text] [Related]
2. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor.
Bhogal N; Donnelly D; Findlay JB
J Biol Chem; 1994 Nov; 269(44):27269-74. PubMed ID: 7961636
[TBL] [Abstract][Full Text] [Related]
3. Defects of tyrosine289phenylalanine mutation on binding and functional properties of the human tachykinin NK2 receptor stably expressed in chinese hamster ovary cells.
Renzetti AR; Catalioto RM; Carloni C; Criscuoli M; Cucchi P; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
Biochem Pharmacol; 1999 Apr; 57(8):899-906. PubMed ID: 10086323
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
[TBL] [Abstract][Full Text] [Related]
5. Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor.
Zoffmann S; Bertrand S; Do QT; Bertrand D; Rognan D; Hibert M; Galzi JL
J Neurochem; 2007 Apr; 101(2):506-16. PubMed ID: 17402972
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.
Warner FJ; Comis A; Miller RC; Burcher E
Br J Pharmacol; 1999 Jul; 127(5):1105-10. PubMed ID: 10455255
[TBL] [Abstract][Full Text] [Related]
7. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of neurokinin A(4-10) at the human tachykinin NK(2) receptor: the effect of amino acid substitutions on receptor affinity and function.
Warner FJ; Miller RC; Burcher E
Biochem Pharmacol; 2002 Jun; 63(12):2181-6. PubMed ID: 12110377
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies at the rat tachykinin NK2 receptor: effect of substitution at position 5 of neurokinin A.
Comis A; Burcher E
J Pept Res; 1999 Mar; 53(3):337-42. PubMed ID: 10231723
[TBL] [Abstract][Full Text] [Related]
10. Presence of NK2 binding sites in the rat brain.
Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
J Neurochem; 2001 Dec; 79(5):985-96. PubMed ID: 11739610
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
12. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.
Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062
[TBL] [Abstract][Full Text] [Related]
13. Human tachykinin NK2 receptor: a comparative study of the colon and urinary bladder.
Warner FJ; Miller RC; Burcher E
Clin Exp Pharmacol Physiol; 2003 Sep; 30(9):632-9. PubMed ID: 12940880
[TBL] [Abstract][Full Text] [Related]
14. Tachykinin NK2 receptors: characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands.
Renzetti AR; Criscuoli M; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):139-44. PubMed ID: 9228201
[TBL] [Abstract][Full Text] [Related]
15. Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig.
Corboz MR; Fernandez X; Rizzo CA; Tozzi S; Monahan ME; Hey JA
Auton Autacoid Pharmacol; 2003 Feb; 23(1):79-93. PubMed ID: 14565542
[TBL] [Abstract][Full Text] [Related]
16. A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties.
Maillet EL; Pellegrini N; Valant C; Bucher B; Hibert M; Bourguignon JJ; Galzi JL
FASEB J; 2007 Jul; 21(9):2124-34. PubMed ID: 17371796
[TBL] [Abstract][Full Text] [Related]
17. A new class of high affinity ligands for the neurokinin A NK2 receptor: psi (CH2NR) reduced peptide bond analogues of neurokinin A4-10.
Harbeson SL; Shatzer SA; Le TB; Buck SH
J Med Chem; 1992 Oct; 35(21):3949-55. PubMed ID: 1331450
[TBL] [Abstract][Full Text] [Related]
18. [125I]His-neurokinin A binds selectively to NK2 receptors of the B-type in rat small intestine smooth muscle membranes.
Brown MC; Biagi M; Renzetti AR; Rovero P; Criscuoli M; Mizrahi J
Eur J Pharmacol; 1992 Oct; 227(2):163-71. PubMed ID: 1330648
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of peptide and nonpeptide NK-2 receptor antagonists binding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis.
Giolitti A; Cucchi P; Renzetti AR; Rotondaro L; Zappitelli S; Maggi CA
Neuropharmacology; 2000 Jun; 39(8):1422-9. PubMed ID: 10818258
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.
Black JL; Diment LM; Alouan LA; Johnson PR; Armour CL; Badgery-Parker T; Burcher E
Br J Pharmacol; 1992 Oct; 107(2):429-36. PubMed ID: 1384914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
